Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
| ▸ | F2 | P00734 | 2/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.54 |
| ▸ | EDNRA | P25101 | 6/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | GBA1 | P04062 | 2/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13911551 | 1.00 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL869336 | 1.00 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL29462219 | 1.00 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL9163130 | 0.88 | HDAC4 (0.58) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL14110615 | 0.88 | HDAC4 (0.48) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL14110750 | 0.85 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL13651429 | 0.85 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5GBA1 | |
| SCHEMBL29358078 | 0.85 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5GBA1 | |
| SCHEMBL597355 | 0.85 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5GBA1 | |
| SCHEMBL18612351 | 0.82 | EDNRA (0.59) | HDAC4HDAC10HDAC6HDAC5F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025080877-A2 | THERAPEUTIC PEPTIDES | FREZENT BIOLOGICAL SOLUTIONS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20240327850-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING RELEASE FACTOR ACTIVITY AND USES THEREOF | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-10-03 | — | — | US | disclosed |
| WO-2024086738-A2 | COMPOSITIONS AND METHODS OF USE FOR INTEINS | GRO BIOSCIENCES INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2022235825-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING RELEASE FACTOR ACTIVITY AND USES THEREOF | Opentrons LabWorks Inc. (US) | 2022-11-10 | — | — | WO | disclosed |
| WO-2022221576-A1 | METHODS FOR CODON OPTIMIZATION AND USES THEREOF | Opentrons LabWorks Inc. (US) | 2022-10-20 | — | — | WO | disclosed |